These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India. Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA Front Public Health; 2022; 10():967447. PubMed ID: 36276377 [TBL] [Abstract][Full Text] [Related]
6. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD; PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774 [TBL] [Abstract][Full Text] [Related]
7. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?]. Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F; Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021. Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841 [TBL] [Abstract][Full Text] [Related]
9. National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic. Palmateer NE; Dickson E; Furrie E; Godber I; Goldberg DJ; Gousias P; Jarvis L; Mathie L; Mavin S; McMenamin J; McNeilly TN; Murcia P; Murray J; Reid G; Robertson C; Templeton K; von Wissmann B; Wallace LA; Waugh C; McAuley A Public Health; 2021 Sep; 198():102-105. PubMed ID: 34411992 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 infection in the general population of Nepal during the first and second generalized waves of the COVID-19 pandemic-2020-2021. Paudel KP; Samuel R; Jha R; Pandey BD; Edirisuriya C; Shrestha NL; Gyawali P; Pokhrel A; Shrestha L; Mahato RK; Hossain SS; Arunkumar G; Bose AS; Dhimal M; Gautam D; Neupane S; Thakur N; Shrestha S; Bhusal N; Jha P; Gupta BP; Rayamajhi RB; Subedi KC; Kandel S; Poudel M; Thapa LB; Sharma GN; Gocotano AE; Sunny AK; Gautam R; Bhatta DR; Awale BK; Roka B; Ojha HC; Baral P; Adhikari MD; Lohani GR; Shrestha M; Singh DR; Aryal L; Pandav RS; Pokhrel R Influenza Other Respir Viruses; 2023 Dec; 17(12):e13234. PubMed ID: 38149926 [TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India. Agarwal D; Patil R; Roy S; Kaur H; Mehandale S; Bavdekar A; Nair H; Juvekar S; Dayma G; J Glob Health; 2023 Apr; 13():06011. PubMed ID: 37079274 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R; Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347 [TBL] [Abstract][Full Text] [Related]
13. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021. Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840 [TBL] [Abstract][Full Text] [Related]
14. A Saliva-Based Serological and Behavioral Analysis of SARS-CoV-2 Antibody Prevalence in Howard County, Maryland. Brown AC; Koshute PT; Cowley HP; Robinette MS; Gravelyn SR; Patel SV; Ju EY; Frommer CT; Zambidis AE; Schneider EJ; Zhao MY; Mugo BK; Clarke W; Kruczynski K; Pisanic N; Heaney CD; Colella TA Microbiol Spectr; 2023 Aug; 11(4):e0276522. PubMed ID: 37289070 [TBL] [Abstract][Full Text] [Related]
15. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil. Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142 [TBL] [Abstract][Full Text] [Related]
16. Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021. Busch MP; Stramer SL; Stone M; Yu EA; Grebe E; Notari E; Saa P; Ferg R; Manrique IM; Weil N; Fink RV; Levy ME; Green V; Cyrus S; Williamson PC; Haynes J; Groves J; Krysztof D; Custer B; Kleinman S; Biggerstaff BJ; Opsomer JD; Jones JM Clin Infect Dis; 2022 Oct; 75(Suppl 2):S254-S263. PubMed ID: 35684973 [TBL] [Abstract][Full Text] [Related]
17. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic. Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Antibody Prevalence in the Portuguese Municipality of Vila Nova de Gaia after the First Wave of the Pandemic. De Carvalho Á; Virgolino A; Queirós P; Henriques AR; Canhão H; Rodrigues AM; Barbosa V; Rodrigues J; Germano de Sousa J; Guimarães M Acta Med Port; 2022 Jun; 35(6):468-475. PubMed ID: 36279518 [TBL] [Abstract][Full Text] [Related]
19. The Seroprevalence of SARS-CoV-2 in Children During Early COVID-19 Pandemic in Korea: A Nationwide, Population-Based Study. Lee J; Choe YJ; Minn D; Kim JH J Korean Med Sci; 2022 Nov; 37(44):e314. PubMed ID: 36377292 [TBL] [Abstract][Full Text] [Related]
20. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021. Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]